Aggressive Growth Micrus Endovascular By: Bill Wilton
February 08, 2010 | Comments: 0
Recommended this article (1)
MEND Print Share
Micrus Endovascular Corp (MEND - Snapshot Report)) shares are surging on the latest quarterly report. The company and analysts have raised their full-year outlook.
Revenues Surging
On Feb 4 Micrus released quarterly results that showed a 24% increase in revenue, to a record high. Sales rose to %22.8 million. Net income came in at $3.3 million, up from a loss one year ago.
Earnings per share were 20 cents, almost triple the Zacks Consensus Estimate of 7 cents. This was the fourth consecutive earnings surprise. The company went on to raise full-year guidance.
The Zacks Consensus for fiscal 2010 is up 2 cents since the report, to 51 cents. Forecasts for next year are averaging 56 cents, 4 cents higher since the report.
Compare these levels to the 70 cent loss Micrus posted last year and the growth is staggering. However, those growth rates are coming at a decent value as shares are trading with a PEG ratio of 0.8.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment